Trial intelligence / Profile preview

S-ketamine for Postoperative Hyperalgesia after VATS

NCT05016128Unknown

Sponsor
Second Affiliated Hospital of Zhejiang University School of Medicine
Start
Aug 2021
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of esketamine in Postoperative hyperalgesia and postoperative pain, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Mechanical pain threshold around the incision at Day 1. Status: unknown.

02

Drugs

esketamine
03

Conditions

Postoperative hyperalgesiapostoperative pain

Beyond the preview

Go deeper on NCT05016128.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05016128.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call